Merrie Cherry, MD
Child & Adolescent Psychiatry · Lexington, SCNPI 1336287762
Payments from drug & device makers
Across 965 payments — averaging $40.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$25K
- Teva Pharmaceuticals USA, Inc.$2K
- AbbVie$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Johnson & Johnson$2K
- Otsuka America Pharmaceutical, Inc.$2K
- plus $5K from 15 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 134 | $24,822 |
| Teva Pharmaceuticals USA, Inc. | 168 | $2,052 |
| AbbVie(2 entities) | 184 | $2,052 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 91 | $2,029 |
| Johnson & Johnson | 98 | $1,903 |
| Otsuka America Pharmaceutical, Inc. | 71 | $1,658 |
| Alkermes, Inc. | 47 | $1,489 |
| Vanda Pharmaceuticals Inc. | 31 | $631 |
| E.r. Squibb & Sons, L.L.C. | 24 | $583 |
| Indivior Inc. | 34 | $467 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $263 |
| Tris Pharma Inc | 14 | $248 |
| Supernus Pharmaceuticals, Inc. | 10 | $193 |
| Corium, LLC | 11 | $189 |
| Noven Therapeutics, LLC | 9 | $154 |
| Lundbeck LLC | 8 | $142 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 3 | $140 |
| Idorsia Pharmaceuticals US Inc | 2 | $131 |
| Axsome Therapeutics, Inc. | 4 | $86 |
| Merck | 4 | $61 |
| Eisai Inc. | 2 | $37 |
How this compares
$39,328 in reported general payments places this provider in the 95th percentile of 71 child & adolescent psychiatry providers in South Carolina.
See all child & adolescent psychiatry providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other child & adolescent psychiatry in Lexington
- Victor EvansLexington$26K
- Don DuboseColumbia$290K
- Mary Theresa LaddCharleston$54K
- David SherbondyGreenville$19K
- Eman SharawyGreenwood$9K
- Elena DlugachGreenville$8K
- Elizabeth JeffordsColumbia$5K
- Vikram ShuklaClover$3K
- Stephanie PriceCharleston$3K
- Adrienne PruittCharleston$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.